Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRVB for Smoking Cessation
NCT03972137Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Apr 2019
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Rutgers University. Primary endpoints: Intervention Feasibility: Participant Attendance at 7 weeks, Intervention Feasibility: Participant Ratings of Effectiveness at 16 weeks and 3 more. Started Apr 2019; status: completed.
Beyond the preview
Go deeper on NCT03972137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03972137.